Smither John W Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$25,000.00
Insider Sells Quantity
8
Insider Sells Sum
$1.1M

Insider Activity of Smither John W

According to the SEC Form 4 filings, Smither John W, being in a position of

  1. director at Genelux Corporation,
    оver the last 12 months, has bought 0 shares, and sold 12000 shares for $34,898,
    over all time since 2023-09-13, has bought 6250 shares for $25,000, and sold 12900 shares for $53,600.

Biography of Smither John W

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $75,4102100

Comparison of Insiders on Amount of Buys and Sells

2026-09-04SaleNewAmsterdam Pharma Company N.V.
NAMS
director
1,600
0.0013%
$25.32$40,512-15.04%
2026-07-01SaleGenelux Corporation
GNLX
director
12,000
0.032%
$2.91$34,898-10.34%
2024-05-29PurchaseGenelux Corporation
GNLX
director
6,250
0.0264%
$4.00$25,000-9.29%
2023-09-13SaleGenelux Corporation
GNLX
director
900
0.0032%
$20.78$18,702-70.18%
2021-03-10SaleArcutis Biotherapeutics, Inc.
ARQT
Chief Financial Officer
3,500
0.0065%
$28.44$99,540-31.06%
2021-03-01SaleArcutis Biotherapeutics, Inc.
ARQT
Chief Financial Officer
1,546
0.0032%
$34.20$52,879-35.34%
2021-02-10SaleArcutis Biotherapeutics, Inc.
ARQT
Chief Financial Officer
5,500
0.01%
$31.01$170,550-35.64%
2021-02-01SaleArcutis Biotherapeutics, Inc.
ARQT
Chief Financial Officer
10,000
0.0183%
$30.84$308,351-32.97%
2021-01-19SaleArcutis Biotherapeutics, Inc.
ARQT
Chief Financial Officer
3,500
0.0067%
$25.95$90,840-13.27%
2020-12-14SaleArcutis Biotherapeutics, Inc.
ARQT
Chief Financial Officer
10,500
0.0198%
$25.95$272,521-9.59%
2020-09-29SaleArcutis Biotherapeutics, Inc.
ARQT
Chief Financial Officer
3,500
0.0078%
$25.95$90,840-14.19%
Total: 11
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.